BeiGene Statistics

Total Valuation

BeiGene has a market cap or net worth of $22.02 billion. The enterprise value is $20.19 billion.

Market Cap	22.02B
Enterprise Value	20.19B

Important Dates

The next estimated earnings date is Friday, November 15, 2024, before market open.

Earnings Date	Nov 15, 2024
Ex-Dividend Date	n/a

Share Statistics

BeiGene has 106.25 million shares outstanding. The number of shares has increased by 0.40% in one year.

Shares Outstanding	106.25M
Shares Change (YoY)	+0.40%
Shares Change (QoQ)	+0.41%
Owned by Insiders (%)	8.03%
Owned by Institutions (%)	45.02%
Float	57.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.89
Forward PS	1.68
PB Ratio	6.44
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	6.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.98, with a Debt / Equity ratio of 0.32.

Current Ratio	1.98
Quick Ratio	1.64
Debt / Equity	0.32
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-242.90

Financial Efficiency

Return on equity (ROE) is -14.62% and return on invested capital (ROIC) is -12.41%.

Return on Equity (ROE)	-14.62%
Return on Assets (ROA)	-9.69%
Return on Capital (ROIC)	-12.41%
Revenue Per Employee	$292,126
Profits Per Employee	-$49,405
Employee Count	10,600
Asset Turnover	0.54
Inventory Turnover	1.22

Taxes

In the past 12 months, BeiGene has paid $52.92 million in taxes.

Income Tax	52.92M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.77% in the last 52 weeks. The beta is 0.63, so BeiGene's price volatility has been lower than the market average.

Beta (5Y)	0.63
52-Week Price Change	+12.77%
50-Day Moving Average	211.91
200-Day Moving Average	171.93
Relative Strength Index (RSI)	42.54
Average Volume (20 Days)	340,079

Short Selling Information

Short Interest	1.51M
Short Previous Month	1.99M
Short % of Shares Out	2.91%
Short % of Float	n/a
Short Ratio (days to cover)	4.20

Income Statement

In the last 12 months, BeiGene had revenue of $3.10 billion and -$523.70 million in losses. Loss per share was -$5.01.

Revenue	3.10B
Gross Profit	2.63B
Operating Income	-887.08M
Pretax Income	-65.61M
Net Income	-523.70M
EBITDA	-795.99M
EBIT	-887.08M
Loss Per Share	-$5.01

Full Income Statement

Balance Sheet

The company has $2.59 billion in cash and $1.09 billion in debt, giving a net cash position of $1.50 billion or $14.14 per share.

Cash & Cash Equivalents	2.59B
Total Debt	1.09B
Net Cash	1.50B
Net Cash Per Share	$14.14
Equity (Book Value)	3.37B
Book Value Per Share	31.73
Working Capital	1.90B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$703.95 million and capital expenditures -$581.37 million, giving a free cash flow of -$1.29 billion.

Operating Cash Flow	-703.95M
Capital Expenditures	-581.37M
Free Cash Flow	-1.29B
FCF Per Share	-$12.10

Full Cash Flow Statement

Margins

Gross margin is 84.98%, with operating and profit margins of -28.65% and -16.91%.

Gross Margin	84.98%
Operating Margin	-28.65%
Pretax Margin	-15.20%
Profit Margin	-16.91%
EBITDA Margin	-25.71%
EBIT Margin	-28.65%
FCF Margin	-5.81%

Dividends & Yields

BeiGene does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.40%
Shareholder Yield	-0.40%
Earnings Yield	-2.41%
FCF Yield	-5.92%

Dividend Details

Analyst Forecast

The average price target for BeiGene is $246.21, which is 18.80% higher than the current price. The consensus rating is "Buy".

Price Target	$246.21
Price Target Difference	18.80%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	84.05%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BeiGene has an Altman Z-Score of 3.04 and a Piotroski F-Score of 2.

Altman Z-Score	3.04
Piotroski F-Score	2